January 10, 2020
Silva MA et al. J Pathol Clin Res 2020;6(2):124-137.
Biomarker recommendation for PD‐1/PD‐L1 immunotherapy development in pediatric cancer based on digital image analysis of PD‐L1 and immune cells.
You might also be interested by
Scientific Publications
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
July 18, 2022
Histopathology
More infoWeb News
CellCarta Launches Advanced AI-Powered Spatial Biology Data for Clinical Trials
March 1, 2022
Histopathology
More info